BAYLINK DAVID J has a total of 11 patent applications. Its first patent ever was published in 1987. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Germany. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are BADYLAK STEPHEN F, KORDIS CORP and SULZER BIOLOG INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | Germany | 2 | |
#4 | United States | 2 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Object sterilising | |
#5 | Implantable devices | |
#6 | Unspecified technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Baylink David J | 9 |
#2 | Kirsch Axel | 2 |
#3 | Ewers Rolf | 2 |
#4 | Linkhart Susan | 2 |
#5 | Baylink David J Prof | 2 |
#6 | Kirsch Axel Dr | 1 |
#7 | Ewers Rolf Prof Dr Dr | 1 |
Publication | Filing date | Title |
---|---|---|
CA2152667A1 | Bone resorption assay | |
WO9315107A1 | Amino procollagen 1(i) peptides | |
US5071655A | Pharmaceutical combination for treatment of bone-wasting diseases | |
US4911931A | Pharmaceutical combination for treatment of bone-wasting diseases |